Visilizumab
id:
visilizumab-306-5299032
title:
Visilizumab
text:
Visilizumab is a humanized monoclonal antibody. It is being investigated for use as an immunosuppressive drug in patients with ulcerative colitis and Crohn's disease. Visilizumab binds to the CD3 receptor on certain activated T cells without affecting resting T cells. It is currently under clinical studies for the treatment of ulcerative colitis and Crohn's disease. PDL BioPharma, Inc. canceled production of visilizumab following its Phase II/III clinical trials, citing its inefficacy and poor s
brand slug:
wiki
category slug:
encyclopedia
description:
Antibody
original url:
https://en.wikipedia.org/wiki/Visilizumab
date created:
date modified:
2023-11-08T17:43:38Z
main entity:
{"identifier":"Q7936102","url":"https://www.wikidata.org/entity/Q7936102"}
image:
fields total:
13
integrity:
14